Alfresa and Sanofi-Aventis co-develop vigabatrin, an antiepilespy drug, in Japan New
Completion of Construction of Aichi Distribution Center by a Subsidiary
Notice of Launch of Joint Distribution between a Subsidiary and ARATA
Consolidated Financial Statements for the Third Quarter of the Fiscal Year Ending March 31, 2012
Conclusion of Basic Agreement on Business Alliance between Alfresa Holdings and Tokiwa Yakuhin
